TOG
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Obstetrician & Gynaecologist 2003;5:1:15-20

Copyright © 2003 by the Royal College of Obstetricians and Gynaecologists.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oepkes, D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Oepkes, D.

Reviews

The modern management of red cell alloimmunisation

Dick Oepkes, MD PhD, Consultant Obstetrician and Gynaecologist

Department of Obstetrics, Leiden University Medical Centre, Netherlands. email: D.Oepkes{at}lumc.nl

Fetal and neonatal haemolytic disease, caused by red cell alloimmunisation, continues to occur despite well-organised prophylaxis programmes. In the average obstetric practice pregnancies complicated by the presence of red cell alloantibodies are now a rarity. Increasingly, these patients are referred to the few specialised fetal medicine units where a team of obstetricians, neonatologists, haematologists, laboratory technicians and transfusion specialists take care of the management in close collaboration. In all these fields advances were made in the last decade, further improving the care of women with this potentially serious condition. In this review current insights and new developments are summarised.

Keywords Keywords / rhesus / alloimmunisation / fetal anaemia / haemolytic disease / pregnancy







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the Royal College of Obstetricians and Gynaecologists.